XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Current Assets    
Cash and cash equivalents $ 5,310 $ 6,092
Short-term investments 2,284 2,406
Accounts receivable (net of allowance for doubtful accounts of $210 in both 2018 and 2017) 7,287 6,873
Inventories (excludes inventories of $1,361 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7) 5,178 5,096
Other current assets 4,005 4,299
Total current assets 24,064 24,766
Investments 10,033 12,125
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,567 in 2018 and $16,602 in 2017 12,626 12,439
Goodwill 18,274 18,284
Other Intangibles, Net 12,898 14,183
Other Assets 7,145 6,075
Total Assets 85,040 87,872
Current Liabilities    
Loans payable and current portion of long-term debt 3,379 3,057
Trade accounts payable 3,024 3,102
Accrued and other current liabilities 9,755 10,427
Income taxes payable 661 708
Dividends payable 1,309 1,320
Total current liabilities 18,128 18,614
Long-Term Debt 19,959 21,353
Deferred Income Taxes 2,159 2,219
Other Noncurrent Liabilities 12,028 11,117
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017 1,788 1,788
Other paid-in capital 39,741 39,902
Retained earnings 41,523 41,350
Accumulated other comprehensive loss (5,122) (4,910)
Stockholders' equity before deduction for treasury stock 77,930 78,130
Less treasury stock, at cost: 907,061,576 shares in 2018 and 880,491,914 shares in 2017 45,401 43,794
Total Merck & Co., Inc. stockholders’ equity 32,529 34,336
Noncontrolling Interests 237 233
Total equity 32,766 34,569
Liabilities and Equity $ 85,040 $ 87,872